Table 1.
Baseline characteristics
| Bangladeshi (n=108) | Whites (n=263) | p Value | |
| Age (years) | 63.0 (12.0) | 68.0 (19.0) | <0.0001 |
| Male sex | 94 (87.0%) | 184 (70.0%) | 0.002 |
| Risk factors | |||
| Smoking | 77 (71.3%) | 185 (70.3%) | 0.85 |
| Hypertension | 47 (43.5%) | 101 (38.4%) | 0.36 |
| Diabetes | 54 (50.0%) | 40 (15.2%) | <0.0001 |
| Family history of IHD | 14 (13.0%) | 77 (29.3%) | 0.0005 |
| Previous AMI | 31 (28.7%) | 48 (18.3%) | 0.0014 |
| Treatment on admission | |||
| Aspirin | 49 (45.4%) | 90 (34.2%) | 0.04 |
| β Blockers | 24 (22.2%) | 31 (11.8%) | 0.011 |
| ACE inhibitors | 27 (25.0%) | 42 (16.0%) | 0.042 |
| Statins | 14 (13.0%) | 26 (10.0%) | 0.20 |
| Emergency treatment | |||
| Aspirin | 107 (99.1%) | 260 (98.9%) | 0.84 |
| β Blockers | 27 (25.0%) | 75 (28.5%) | 0.50 |
| Thrombolysis | 92 (85.2%) | 212 (80.6%) | 0.30 |
| Treatment delay (minutes) | |||
| Door to needle time | 42.5 (78.0) | 26.0 (47.7) | 0.012 |
| Pain to needle time | 64.5 (117.5) | 63.0 (140.3) | 0.63 |
| Discharge medication | |||
| Aspirin | 97 (90.7%) | 228 (88.7%) | 0.55 |
| β Blockers | 69 (65.1%) | 159 (61.9%) | 0.81 |
| ACE inhibitors | 71 (67.0%) | 134 (52.1%) | 0.031 |
| Statins | 56 (52.8%) | 155 (60.3%) | 0.27 |
| Infarction | |||
| Peak CK rise (IU/l) | 1001 (1739) | 813 (1143) | 0.10 |
| LVF | 27 (25.2%) | 53 (20.2%) | 0.39 |
Data are absolute number (%) or value (interquartile range).
ACE, angiotensin converting enzyme; AMI, acute myocardial infarction; CK, creatine kinase; IHD, ischaemic heart disease; LVF, left ventricular failure.